PatternsRadar
Sign in

INDSWFTLABInd-Swift Laboratories Limited

NSE
Full chart
400.45INR+14.70 (+3.81%)Close · 6 Oct 2026
10 Aug 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹3,482 CrMarket cap
60.7P/E (TTM)
46.0%Delivery

Filings & corporate actions

78 results filed
CSV
Next results · Q2 FY27
Expected 2 Nov 2026 – 14 Nov 2026
Estimate: filed 33–45 days after quarter end, last 5 times
2026
  • 10 AugresultsResults · Q1 FY27 · consolidated and standalone+20.0%NSE
  • 20 JulshareholdingShareholding · 30 Jun 2026+1.1%NSE
  • 28 MayresultsResults · Q4 FY26 · consolidated and standalone+12.8%NSE
  • 21 AprshareholdingShareholding · 31 Mar 2026+3.6%NSE
  • 5 MarshareholdingShareholding · 24 Feb 2026+8.7%NSE
  • 31 JanresultsResults · Q3 FY26 · consolidated and standalone-0.6%NSE
  • 21 JanshareholdingShareholding · 31 Dec 2025-1.1%NSE

Reaction to results · all yearsrose on day 0 in 33 of 78 CSV

QuarterFiledDay 0+5D+20DRel vol
Q1 FY2710 Aug 2026+20.0%+46.2%+63.7%20.1×
Q4 FY2628 May 2026+12.8%+17.2%+52.2%13.5×
Q3 FY2631 Jan 2026-0.6%+16.6%+28.1%0.8×
Q2 FY2614 Nov 2025-4.0%-7.7%-5.9%2.8×
Q1 FY2613 Aug 2025-3.9%-7.2%+0.1%0.5×
Q4 FY2512 Aug 2025+0.5%-3.5%+4.4%0.3×
Q3 FY2514 Feb 2025+3.8%-0.8%+1.7%2.5×
Q2 FY2512 Nov 2024-2.0%-8.5%+3.1%0.8×
Q1 FY2513 Aug 2024-4.6%-15.9%-7.3%1.1×
Q4 FY2414 May 2024+2.9%-2.3%+8.5%1.8×
Q3 FY2412 Feb 2024-3.9%+8.0%+3.8%1.4×
Q2 FY248 Nov 2023-0.7%-0.4%-4.0%1.1×
Q1 FY2410 Aug 2023-1.9%-8.0%-5.5%0.6×
Q4 FY2330 May 2023-0.8%-0.1%+19.9%0.9×
Q3 FY2315 Feb 2023+0.8%-2.2%-8.9%1.5×
Q2 FY239 Nov 2022+20.0%+20.2%+21.3%32.6×
Q1 FY2310 Aug 2022+0.5%+5.5%+0.8%0.9×
Q4 FY2229 May 2022-5.1%+2.4%+2.2%2.8×
Q3 FY229 Feb 2022-8.3%-15.9%-21.2%1.7×
Q2 FY222 Nov 2021+10.0%+21.0%+21.9%1.9×
Q1 FY2213 Aug 2021+3.6%-23.1%-8.3%0.2×
Q4 FY2130 Jun 2021-11.3%-4.4%+4.6%1.3×
Q3 FY2113 Feb 2021-5.0%-6.9%+10.8%1.6×
Q2 FY2110 Nov 2020+0.6%+23.2%+23.0%0.6×
Q1 FY2125 Jul 2020-5.0%-0.7%+8.0%3.8×
Q4 FY2021 Jun 2020-1.0%-14.8%-10.1%5.2×
Q3 FY2014 Feb 2020+0.7%-2.8%-15.0%1.3×
Q2 FY2012 Nov 2019-4.5%-6.9%-18.6%1.7×
Q4 FY199 Sept 2019+0.2%+0.9%-12.3%1.2×
Q1 FY2010 Aug 2019+2.1%+5.5%+37.4%3.0×
Q3 FY1919 Feb 2019+6.5%+1.3%-1.0%3.0×
Q2 FY1927 Nov 2018-0.5%-6.8%-16.6%1.1×
Q1 FY1931 Aug 2018+1.6%-1.7%-31.0%0.8×
Q4 FY1829 Jun 2018-2.6%+3.1%-5.8%0.5×
Q3 FY1828 Feb 2018-2.7%-7.3%-13.0%1.2×
Q2 FY1826 Dec 2017+10.0%+15.9%-5.5%3.1×
Q1 FY1822 Sept 2017-2.7%-3.0%-1.2%0.7×
Q4 FY1715 Jun 2017+2.4%0.0%-0.4%0.9×
Q3 FY1715 Feb 2017-0.6%+2.2%+1.5%0.6×
Q2 FY1715 Nov 2016-1.1%-3.0%+3.6%0.3×
Q1 FY1713 Aug 2016-0.7%-4.1%+4.8%0.9×
Q4 FY1626 May 2016-2.3%+1.5%-4.9%0.8×
Q3 FY1615 Feb 2016-6.5%-10.0%+15.6%0.6×
Q2 FY1627 Oct 2015-1.8%-8.4%-6.6%0.5×
Q1 FY1613 Aug 2015-0.1%+1.3%-18.4%0.8×
Q4 FY1521 May 2015-1.0%+2.8%-3.8%1.0×
Q3 FY1510 Feb 2015+5.9%+11.2%+8.8%2.5×
Q2 FY1513 Nov 2014-2.6%-5.8%-16.3%0.5×
Q1 FY1518 Aug 2014-2.2%+2.8%+16.2%0.3×
Q4 FY141 Jul 2014-3.4%-9.8%-15.4%0.5×
Q3 FY1412 Feb 2014+4.2%+0.6%+18.8%0.9×
Q2 FY1422 Nov 2013-1.3%+6.5%+26.0%1.3×
Q1 FY1414 Aug 2013-0.4%-1.3%-0.2%1.3×
Q4 FY1314 Jun 2013-0.4%-2.4%-3.3%0.8×
Q3 FY1319 Feb 2013+0.1%-0.2%-0.6%1.0×
Q2 FY138 Nov 2012-2.9%-8.6%-11.9%0.9×
Q1 FY1323 Aug 2012+12.0%+8.4%+28.8%12.5×
Q4 FY126 Jun 2012-0.1%-7.2%-17.1%2.2×
Q3 FY129 Feb 2012-1.5%-4.3%-18.9%1.3×
Q2 FY1216 Nov 2011-4.3%-21.0%-19.5%0.6×
Q1 FY1220 Aug 2011+2.3%+1.5%+17.1%0.8×
Q4 FY1126 May 2011-0.4%+3.1%-3.2%2.1×
Q3 FY1131 Jan 2011+1.7%+7.4%-3.7%4.5×
Q2 FY1115 Nov 2010+1.0%-11.6%-30.0%0.9×
Q1 FY1129 Jul 2010-1.1%-2.1%+53.3%0.4×
Q4 FY1031 May 2010+5.2%-0.3%+11.4%4.2×
Q3 FY1028 Jan 2010+3.0%-0.4%-4.0%0.8×
Q2 FY1030 Oct 2009-5.2%+4.7%+8.2%0.5×
Q1 FY1030 Jul 2009+1.9%+14.7%+47.5%1.6×
Q4 FY0929 Jun 2009-0.7%-10.3%-1.3%1.1×
Q3 FY0929 Jan 2009+2.3%-1.6%-6.6%0.9×
Q2 FY0925 Oct 2008-3.8%+16.8%-0.4%1.0×
Q1 FY0930 Jul 2008+4.9%+5.3%+2.2%4.7×
Q4 FY0819 Jun 2008-3.7%-13.7%-19.3%2.1×
Q3 FY0829 Jan 2008-3.7%+1.2%+1.5%0.5×
Q2 FY0829 Oct 2007+0.8%-0.1%+10.0%1.3×
Q1 FY0810 Aug 2007+0.9%-11.0%-0.5%0.3×
Q4 FY073 May 2007+0.8%-7.1%-7.9%1.8×
Average+0.3%-0.2%+2.4%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV
Revenue YoY+25.4%
Profit YoY+181.3%
Interest cost YoY—
Revenue QoQ+12.8%
Profit QoQ+63.3%
CAGR2Y3Y4Y5Y6Y7Y
Revenue-18.6%-18.7%-11.2%—-3.0%—
Profit-55.6%+7.6%————

Key data

CSV
Open388.70
Day range386.90 – 401.50
52-week range87.15 – 424.75
From 52w high-5.7%
RSI (14)59.9
ATR (14)23.15
Volume3.70L
Avg volume (20D)7.66L
Rel volume0.48×
Volatility (1Y)56.1%
Turnover₹14.8Cr
SMA 50 / 200334.28 / 192.18

Delivery percentage

Latest · 6 Oct 202646.0%
20-day avg39.3%
1-year avg50.5%
Percentile (own history)16th
Range8.0–100.0%
Sessions1,731

Over the last 20 sessions INDSWFTLAB settled 39.3% of its traded quantity, which is ordinary for an NSE equity. Its one-year average is 50.5%, so recent sessions are running 11.2 points lower than usual. The latest session ranks higher than 16% of the 1,731 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

IndustryPharmaceuticals
PeersDIVISLABLAURUSLABSSUNPHARMAWOCKPHARMADRREDDYMOREPENLAB

Performance returns

CSV
1D1W1M3M6M1Y
Price+3.81%-1.87%+7.45%+86.13%+188.40%+300.73%

Valuation

CSV
Market cap₹3,482 Cr
P/E (TTM)60.7
EPS (TTM)6.59
Shares outstanding8.68Cr
Listed2 Jul 1997

Ownership

CSV
Promoter42.93%
Promoter Δ QoQ-0.06 pp
Public57.07%
FII10.70%
DII0.17%
Pledged0.00%

Quarterly results · consolidated

CSV
Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue (₹ Cr)152.6150.9169.8191.5
YoY chg+1176.6%+1641.1%+22.8%+25.4%
Net profit (₹ Cr)8.09.515.124.7
YoY chg+1833.3%+153741.9%-93.2%+181.3%
Net margin5.2%6.3%8.9%12.9%
EPS0.961.131.762.84

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 42.93% · public 57.07%
30 Sept 2021: promoter 42.00%31 Dec 2021: promoter 42.00%31 Mar 2022: promoter 42.00%30 Jun 2022: promoter 42.00%30 Sept 2022: promoter 42.00%31 Dec 2022: promoter 42.00%31 Mar 2023: promoter 42.00%30 Jun 2023: promoter 42.00%30 Sept 2023: promoter 42.00%31 Dec 2023: promoter 42.00%31 Mar 2024: promoter 42.00%30 Jun 2024: promoter 42.00%30 Aug 2024: promoter 42.00%30 Sept 2024: promoter 42.00%31 Dec 2024: promoter 42.00%18 Mar 2025: promoter 40.94%31 Mar 2025: promoter 40.94%30 Jun 2025: promoter 40.94%2 Jul 2025: promoter 38.57%21 Jul 2025: promoter 36.77%1 Aug 2025: promoter 37.72%25 Aug 2025: promoter 39.50%30 Sept 2025: promoter 39.50%31 Dec 2025: promoter 39.50%24 Feb 2026: promoter 43.06%31 Mar 2026: promoter 42.99%30 Jun 2026: promoter 42.93%
2021-092026-06
  • Promoter
  • Public and others
Promoter
42.93%
Public
57.07%
Promoter change
-0.06 pp
Filed
20 Jul 2026
FII
10.70%
DII
0.17%
Promoter pledged
0.00%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
₹ crore, as filed
 Q2 FY24Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27
Revenue from operations289.7287.5393.333.212.08.7138.2152.7152.6150.9169.8191.5
Other income7.47.125.311.113.013.84.514.617.927.62.27.7
Total income297.1294.6418.644.325.022.5142.7167.3170.5178.4172.0199.1
Total expenses258.3270.9431.843.324.423.6128.1157.0160.2156.2154.9166.3
└ Finance costs21.121.1(11.5)0.20.40.1(26.8)1.22.00.7(2.4)0.7
└ Depreciation13.213.612.70.20.20.27.46.77.08.88.17.6
Profit before tax38.823.8373.31.00.6(1.1)230.510.410.316.412.032.6
Tax expense6.94.2134.5(0.0)0.2(1.1)8.21.72.34.0(3.1)8.0
Net profit31.719.4238.90.90.40.0222.38.88.09.515.124.7
EPS5.363.2940.420.160.070.0032.961.281.001.171.812.84
Net margin10.93%6.75%60.73%2.82%3.46%0.07%160.79%5.74%5.23%6.32%8.90%12.89%
PBT margin13.38%8.27%94.92%2.95%4.88%-12.48%166.72%6.78%6.78%10.87%7.04%17.01%
Tax rate17.89%17.86%36.02%-2.94%31.61%—3.55%16.47%22.24%24.40%-26.34%24.54%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 10 Aug 2026.

INDSWFTLAB at a glance

  • INDSWFTLAB closed at ₹400.45 on 6 Oct 2026, +3.81% on the day, +300.7% over one year, 5.7% below its 52-week high of ₹424.75.
  • Delivery was 46.0% of traded quantity on 6 Oct 2026, the 16th percentile of its own 1,731 sessions with a reading (20-session average 39.3%, 1-year average 50.5%).
  • Market capitalisation is ₹3,482 crore at a trailing P/E of 60.7 (trailing EPS ₹6.59).
  • Q1 FY27 results (consolidated, filed 10 Aug 2026): revenue ₹191 crore (+25.4% year on year), net profit ₹25 crore (+181.3%); the price moved +20.0% on the first session after.
  • Promoters held 42.93% at 30 Jun 2026, down 0.06 percentage points on the previous filing.
  • Q2 FY27 results are expected between 2 Nov 2026 and 14 Nov 2026, going by past filing dates — an estimate, not an announcement.

About

CSV
Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE915B01019
SeriesEQ
Listed2 Jul 1997
History from16 Jul 1997
Sessions7,126
Turnover rank#633

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.

More in Pharmaceuticals & Biotechnology

CSV

All Pharmaceuticals & Biotechnology stocks on the NSEAll Healthcare stocks on the NSE